Moreover, miR-23b is commonly repressed in autoimmune conditions via IL-17 (ref. 24), a cytokine shown to promote myeloma cell growth.35 We have indeed observed further decrease in miR-23b expression in MM cells after IL-17 treatment for 24 h. This evidence concerns the gene IL17A and Miyoshi myopathy.